Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Henlius Biotech, Inc. has provided additional details on their internal control measures for managing continuing connected transactions under their Business Travel Management Services and General Procurement Framework Agreements. These measures include regular reviews, adherence to approved internal guidelines, monthly reporting by the Finance Department, and annual reviews by independent directors and auditors to ensure compliance with the Listing Rules.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.